Glutathione S-transferase T1, M1 and P1 Genetic Polymorphisms and Susceptibility to Colorectal Cancer in Turkey

  • Gorukmez, Ozlem (Department of Medical Genetics, School of Medicine, Uludag University) ;
  • Yakut, Tahsin (Department of Medical Genetics, School of Medicine, Uludag University) ;
  • Gorukmez, Orhan (Sevket Yilmaz Training and Research Hospital, Medical Genetics Unit) ;
  • Sag, Sebnem Ozemri (Department of Medical Genetics, School of Medicine, Uludag University) ;
  • Topak, Ali (Department of Medical Genetics, School of Medicine, Uludag University) ;
  • Sahinturk, Serdar (Department of Medical Genetics, School of Medicine, Uludag University) ;
  • Kanat, Ozkan (Department of Medical Oncology, School of Medicine, Uludag University)
  • Published : 2016.08.01


Colorectal cancer (CRC) is reproted to be the third most common cancer worldwide and the fourth most common cause of cancer related deaths. CRC is considered to be a multifactorial disease whose risk varies due to the complex interaction between individual genetic basis and disposure to multiple endogenous factors. Glutathione S-transferases are pro-carcinogenic in CRC and are required for the conjugation between chemotherapeutics and broad spectrum xenobiotics. One hundred and eleven patients with CRC and 128 control subjects without any cancer history were enrolled in this study. Multiplex PCR was applied to determine polymorphisms for the GSTT1 and M1 genes, and PCR-RFLP was applied for the GSTP1 (Ile105Val) gene polymorphism. Values p<0.05 were defined as statistically significant. We detected a significant high correlation between predisposition for CRC and presence of the Ile/Ile genotype of the GSTP1 (IIe105Val) gene polymorphism, but we did not find a significant relationship between predisposition for CRC and GSTT1 and M1 deletion polymorphisms. In addition, we did not determine a relationship between GSTT1, M1 and P1 gene polymorphisms and any clinicopathological features of CRC. GSTT1 null/GSTM1 positive and GSTT1 null/GSTM1 positive/GSTP1 Ile/Ile genotypes were significantly higher in the patient group. Our results revealed that there is no relationship among CRC, its clinicopathologic features, and GSTT1 M1 gene polymorphisms. However, there was a significant correlation between CRC and the GSTP1 Ile/Ile genotype. Further studies with larger patient groups are required to delineate the relationships between GST gene polymorphisms and the clinicopathologic features of CRC in Turkey.


  1. Abbas A, Delvinquiere K, Lechevrel M, et al (2004). GSTM1, GSTT1, GSTP1 and CYP1A1 genetic polymorphisms and susceptibility to esophageal cancer in a French population: different pattern of squamous cell carcinoma and adenocarcinoma. World J Gastroenterol, 10, 3389-93.
  2. Ali-Osman F, Akande O, Antoun G, Mao JX (1997). Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem, 272, 10004-12.
  3. Ates NA, Unal M, Tamer L, et al (2005). Glutathione S-transferase gene polymorphisms in presbycusis. Otol Neurotol, 26, 392-7.
  4. Board PG, Menon D (2013). Glutathione transferases, regulators of cellular metabolism and physiology. Biochimica et Biophysica Acta, 1830, 3267-88.
  5. Cunningham D, Atkin W, Lenz HJ, et al (2010). Colorectal cancer. Lancet, 375, 1030-47.
  6. De Jong MM, Nolte IM, teMeerman GJ, et al (2002). Lowpenetrance genes and their involvement in colorectal cancer susceptibility. Cancer Epidemiol Biomarkers Prev, 11, 1332-52.
  7. De la Chapelle A (2004). Genetic predisposition to colorectal cancer. Nat Rev Cancer, 4, 769-80.
  8. Economopoulos KP, Sergentanis TN (2010). STM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis. Eur J Cancer, 46, 1617-31.
  9. Gao Y, Cao Y, Tan A, et al (2010). Glutathione S-transferase M1 polymorphism and sporadic colorectal cancer risk: An updating meta-analysis and HuGE review of 36 case-control studies. Ann Epidemiol, 20, 108-21.
  10. Garte S, Gaspari L, Alexandrie AK, et al (2001). Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev, 10, 1239-48.
  11. Goodman JE, Mechanic LE, Luke BT, et al (2006). Exploring SNP-SNP interactions and colon cancer risk using polymorphism interaction analysis. Int J Cancer, 118, 1790-7.
  12. Hayes JD, Pulford DJ (1995). The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol, 30, 445-600.
  13. Hezova R, Bienertova-Vasku J, Sachlova M, et al (2012). Common polymorphisms in GSTM1, GSTT1, GSTP1, GSTA1 and susceptibility to colorectal cancer in the Central European population. Eur J Med Res, 17, 17.
  14. Hunter DJ, Riboli E, Haiman CA, et al (2005). A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer, 5, 977-85.
  15. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
  16. Khabaz MN (2012). The GSTP1 Ile105Val polymorphism is not associated with susceptibility to colorectal cancer. Asian Pac J Cancer Prev, 13, 2949-53.
  17. Kiran B, Karkucak M, Ozan H et al (2010). GST (GSTM1, GSTT1, and GSTP1) polymorphisms in the genetic susceptibility of Turkish patients to cervical cancer. J Gynecol Oncol, 21, 169-73.
  18. Klusek J, Gluszek S, Klusek J. (2014). GST gene polymorphisms and the risk of colorectal cancer development. Contemp Oncol, 18, 219-21.
  19. Koh WP, Nelson HH, Yuan JM, et al (2011). Glutathione S-transferase (GST) gene polymorphisms, cigarette smoking and colorectal cancer risk among Chinese in Singapore. Carcinogensis, 32, 1507-11.
  20. Lai CY, Hsieh LL, Sung FC et al (2013). Tumor site- and stagespecific associations between allelic variants of glutathione s-transferase and DNA repair genes and overall survival in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy. PLoS One, 23, 8.
  21. Landi S (2000). Mammalian class theta GST and differential susceptibility to carcinogens:a review. Mutat Res, 463, 247-83.
  22. Moscow JA, Fairchild CR, Madden MJ, et al (1989). Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res, 49, 1422-8.
  23. Piao JM, Shin MH, Kweon SS, et al (2009). Glutathione-Stransferase (GSTM1, GSTT1) and the risk of gastrointestinal cancer in a Korean population. World J Gastroenterol, 15, 5716-21.
  24. Reszka E, Wasowicz W, Gromadzinska J (2006). Genetic polymorphism of xenobiotic metabolising enzymes, diet and cancer susceptibility. Br J Nutr, 96, 609-19.
  25. Tabor HK, Risch NJ, Myers RM (2002). Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet, 3, 391-7.
  26. Terrier P, Townsend AJ, Coindre JM et al (1990). An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am J Pathol, 137, 845-53.
  27. Wang J, Jiang J, Zhao Y, et al (2011). Genetic polymorphisms of glutathione S-transferase genes and susceptibility to colorectal cancer: a case-control study in an Indian population. Cancer Epidemiol, 35, 66-72.
  28. Welfare M, Monesola Adeokun A, Bassendine MF, Daly AK (1999). Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer. Cancer Epidemiol Biomarkers Prev, 8, 289-92.
  29. Zimniak P, Nanduri B, Pikula S (1994). Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur J Biochem, 224, 893-9.